Back to DIMENSIONAL FUND ADVISORS LP DIMENSIONAL FUND ADVISORS LP

FDMTFDMT
Showing 8 of 14 quarters

Position history for DIMENSIONAL FUND ADVISORS LPDIMENSIONAL FUND ADVISORS LP's holdings in 4D MOLECULAR THERAPEUTICS IN

Yes. Dimensional Fund Advisors holds 730,857 shares of FDMT (4D Molecular Therapeutics in), worth $9.7M, as of its Q2 2026 13F filing. It increased the position by 208,034 shares (+39.8%) from Q1 2026. Dimensional Fund Advisors has held FDMT since Q1 2023, across 14 quarterly 13F filings.

Current Value

$9.7M

Current Shares

730,857

Total Value Change

+$7.5M

Total Shares Change

+522,042

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
730,857
+39.8%
$9.7M0.0%$13.30
37
2026-Q1
Increased
522,823
+77.3%
$4.9M0.0%$8.46
41
2025-Q4
Increased
294,841
+408.3%
$2.2M0.0%$7.58
42
2025-Q3
Increased
58,006
+3.7%
$503,5200.0%$8.35
25
2025-Q2
Decreased
55,937
-25.0%
$207,7370.0%$3.84
0
2025-Q1
Decreased
74,566
-43.5%
$241,4980.0%$3.63
0
2024-Q4
Decreased
131,965
-36.8%
$734,6070.0%$5.30
0
2024-Q3
Decreased
208,815
-60.8%
$2.3M0.0%$10.83
0

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used